December 26, 2018 Gerald Solensky Chief Executive Officer Zomedica Pharmaceuticals Corp. 100 Phoenix Drive, Suite 190 Ann Arbor, MI 48108 Re: Zomedica Pharmaceuticals Corp. Registration Statement on Form S-3 Filed December 20, 2018 File No. 333-228926 Dear Mr. Solensky: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Donald Field at 202-551-3680 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance